Medical/Pharmaceuticals
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
SEOUL, South Korea, Aug. 12, 2021 /PRNewswire/ -- Fujifilm Corporation, a global medical imaging device provider, today announced its AI-powered product for analyzing chest X-ray 'CXR-AID' will be commercially available acrossJapan. CXR-AID is designed to better detect major abnormal findings ...
Zhongchao Inc. Builds A Patient DOT Management System
SHANGHAI, China, Aug. 12, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zho...
Sri Kota Specialist Medical Centre Honoured at the Asia Pacific Enterprise Awards 2021 Regional Edition
SINGAPORE, Aug. 12, 2021 /PRNewswire/ -- Enterprise Asia, the organiser of the prestigious fifteenth Asia Pacific Enterprise Awards (APEA) 2021 Regional Edition is pleased to recognise 59 exceptional award recipients who have exemplified excellence and perseverance in this unprecedented period. T...
UKM collaborated in an international study of mortality rates for babies with birth defects
BANGI, Malaysia, Aug. 12, 2021 /PRNewswire/ -- The Paediatric Surgery Unit of the Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), sees the culmination of a three-year effort when their international collaborative research found that the survival of a baby born with a birth defect is g...
Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia
SAN FRANCISCO and SUZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002
HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative drug development company, announced today that it has administered its triple-kinase inhibitor LNK01002 to the first patient in a phase I clinical trial...
Dassiet and OrthoPets Collaborate to Provide Safer and Easier Orthopedic Care for Pets
The teams combine Dassiet's clinically proven medical and material innovations with OrthoPets strong experience in custom pet orthoses to provide human level care for animals. ESPOO, Finland and WESTMINSTER, Colo., Aug. 11, 2021 /PRNewswire/ -- The material innovation company Dassiet, and the le...
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director
HONG KONG, Aug. 11, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, today announced the appointment ofSteven Galson, MD, MPH as the independent member of the board of directors. "Successful drug development depends on speed and increasing the rates...
Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry
HONG KONG, Aug. 11, 2021 /PRNewswire/ -- On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the"Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' pu...
Invitation to the presentation of Elekta's first quarter 2021/22
STOCKHOLM, Aug. 11, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2021/22 at10:00 a.m. CEST onAugust 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day. The company's development will be...
PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021
JAKARTA, Indonesia, Aug. 11, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...
Zuellig Pharma Singapore Named 'Industry Champions of the Year' at the Asia Corporate Excellence & Sustainability Awards 2021
SINGAPORE, Aug. 11, 2021 /PRNewswire/ -- Zuellig Pharma Singapore, a leading healthcare services provider inSingapore, has been presented with the 'Industry Champions of the Year' title at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. Held annually, the ACES Awards is a p...
Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021 Exploring The Profiles Of Australian Contour®Diabetes App Users
SYDNEY, Aug. 11, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes placeAugust 11-13. The two posters presented for the first time data that analysed CONTOUR®DIABETES App (CDA) us...
DERMALOG is one of Germany's most innovative SMEs
Again, DERMALOG has been ranked as one of the most innovative companies in Germany this year. The biometrics company thus ranks in the top group as number 14 of the approximately 4,000 German companies evaluated HAMBURG, Germany, Aug. 10, 2021 /PRNewswire/ -- The German WirtschaftsWoche magazine...
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with Its Systems Integration Solution
LONDON, Aug 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global market for operating room (OR) systems integration,Frost & Sullivan recognizes FUJIFILM Medical SystemsUSA, Inc. with the 2021 Global New Product Innovation Award. Its systems integration solution comprising Intellige...
Novaliq Completes Enrollment of Second Phase 3 Study for CyclASol® for the Treatment of Dry Eye Disease
HEIDELBERG, Germany and CAMBRIDGE, MA, Aug. 10, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the inves...
Dymicron® Names Gunther Peeters as Senior Vice President of Commercial Operations
Gunther Peeters to spearhead international commercialization of Dymicron's next-generation cervical disc replacement system OREM, Utah, Aug. 10, 2021 /PRNewswire/ -- Dymicron today announced it has appointedGunther Peeters as Senior Vice President of Commercial Operations. With more than 15 year...
Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine
* Contributing to society and patients through the utilization of iPSC technology developed inJapan * New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application of iPSC-based medicine KYOTO, Japan, Aug. 10, 2...
Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic
'New Normal, Same Cancer: Conversations' warns people to get unusual and persistent symptoms checked by their doctor now, to increase detection and improve survival chances, following a slump in cancer testing and screening during the COVID-19 pandemic. * Growing concern among Australian cance...
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 317 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 300 media titles]
2024-05-16 15:00Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 271 media titles]
2024-05-16 09:39Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01